One of the key scientists behind Oxford university’s malaria vaccine has criticised the World Health Organization’s lack of “urgency” after the global health body targeted mid-2024 for distribution of the jab.
Adrian Hill said the health body had not consulted the university before disclosing the planned timeframe on Monday when it recommended the R21/Matrix-M vaccine for use in children.
Health experts see the shot as a game-changer that will help combat the tropical disease. Oxford’s partnership with the Serum Institute of India, the world’s largest vaccine maker by doses, gives it much bigger production capacity than pharma group GSK has for its RTS,S shot, the first malaria vaccine approved for use in 2021.
您已閱讀20%（718字），剩餘80%（2842字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。